[Federal Register Volume 65, Number 239 (Tuesday, December 12, 2000)]
[Notices]
[Page 77635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-31588]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 00N-1353]


Agency Information Collection Activities; Announcement of OMB 
Approval; Current Good Manufacturing Practices and Related Regulations 
for Blood and Blood Components

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Current Good Manufacturing 
Practices and Related Regulations for Blood and Blood Components'' has 
been approved by the Office of Management and Budget (OMB) under the 
Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of July 6, 2000 (65 
FR 41674), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0116. 
The approval expires on November 30, 2003. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.

    Dated: December 5, 2000.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 00-31588 Filed 12-11-00; 8:45 am]
BILLING CODE 4160-01-F